Kristen Krysko, MD, on Newer vs Injectable Disease-Modifying Therapies for Initial Treatment of Pediatric MS

In this video, Dr Krysko discusses the findings from her study on the real-world effectiveness of newer vs injectable disease-modifying therapies among pediatric patients with multiple sclerosis. This study was featured in the 2020 American Academy of Neurology Science Highlights. Read the transcript here.

For more videos like this, visit Neurology Consultant.

Reference:

  1. Krysko K, Graves J, Rensel M, et al. Real-world effectiveness of initial treatment with newer versus injectable disease-modifying therapies in pediatric multiple sclerosis. Neurology. 2020;94(15 suppl.). https://n.neurology.org/content/94/15_Supplement/625

Kristen Krysko, MD, is a neurologist and multiple sclerosis/neuroimmunology clinical research fellow at the University of California, San Francisco.